Mammary Cell News Volume 16.16 | Apr 25 2024

    0
    12







    2024-04-25 | MCN 16.16


    Mammary Cell News by STEMCELL Technologies
    Vol. 16.16 – 25 April, 2024
    TOP STORY

    Procoagulant Platelets Promote Immune Evasion in Triple Negative Breast Cancer

    Scientists reported that procoagulant platelets beared large amounts of immune checkpoint molecules and that the presence of these cellular blood components in TNBC related to pro-tumorigenic immune cell activity and impaired survival.
    [Blood]

    Abstract
    Animal Origin-Free cGMP HSPC Expansion Media
    PUBLICATIONSRanked by the impact factor of the journal

    Chemotherapy-Elicited Extracellular Vesicle CXCL1 from Dying Cells Promotes Triple-Negative Breast Cancer Metastasis by Activating TAM/PD-L1 Signaling

    Investigators highlighted CXCL1EV-dead as a novel dying cell-released signal and provided TPCA-1 as a targeting candidate to improve TNBC prognosis.
    [Journal Of Experimental & Clinical Cancer Research]

    Full ArticleGraphical Abstract

    Toxoplasma gondii Suppresses Proliferation and Migration of Breast Cancer Cells by Regulating Their Transcriptome

    The effect of tachyzoites of T. gondii on human breast cancer cells proliferation and migration was assessed using cell growth curve and wound healing assays.
    [Cancer Cell International]

    Full Article

    68Ga Labeled EphA2-Targeted Cyclic Peptide: A Novel Positron Imaging Tracer for Triple-Negative Breast Cancer?

    To develop a novel PET imaging agent, we prepared gallium-68 (68Ga) labeled-DOTA-SD01 and evaluated its specificity and effectiveness through micro PET/CT imaging in a TNBC-bearing mouse model.
    [Dalton Transactions]

    AbstractGraphical Abstract

    Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists As Potential Migrastatics for Triple Negative Breast Cancer

    Researchers reported the synthesis and biological evaluation of fluorine-containing triazole derivatives as potent lysophosphatidic acid receptor 1 (LPA1) antagonists, offering potential as migrastatic drugs for triple negative breast cancer.
    [ChemMedChem]

    Abstract

    The Ras-Related Protein RAB22A Interacts with Hypoxia-Inducible Factor 1-Alpha (HIF-1α) in MDA-MB-231 Breast Cancer Cells in Hypoxia

    Investigators determined whether these two proteins were present in intracellular complexes in breast carcinoma cells. Evaluation using molecular docking indicated that HIF-1α and RAB22A interact with each other.
    [Molecular Biology Reports]

    Abstract
    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    REVIEWS

    miR-192 Family in Breast Cancer: Regulatory Mechanisms and Diagnostic Value

    The authors describe the regulatory mechanism of the miRNA-192 family affecting the malignant behavior of breast cancer cells and evaluate the value of the miRNA-192 family as a diagnostic and prognostic biomarker for breast cancer.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Evexta Bio Reports Progress towards Clinical Development of Rupitasertib in Advanced Breast Cancer

    Evexta Bio SA provided an update on the clinical development of its lead asset, rupitasertib, a selective oral inhibitor of S6K and AKT1/AKT3.
    [Evexta Bio SA]

    Press Release
    FEATURED EVENT

    ISCT 2024

    May 29 – June 1, 2024
    Vancouver, British Columbia, Canada

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Breast Cancer

    University of Miami – Miami, Florida, United States

    Laboratory Research Technician – Pathology

    University of Pittsburgh – Pittsburgh, Pennsylvania, United States

    Research Technician – Ovarian & Breast Cancer

    Indiana University School of Medicine – Indianapolis, Indiana, United States

    Postdoctoral Fellow – Cancer Research

    Medical College of Wisconsin – Milwaukee, Wisconsin, United States

    Postdoctoral Fellow – Biochemistry and Molecular Biology

    Indiana University School of Medicine – Indianapolis, Indiana, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2